Literature DB >> 15724876

Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders.

M Majer1, M Ising, H Künzel, E B Binder, F Holsboer, S Modell, J Zihl.   

Abstract

BACKGROUND: This study addresses the complex relationship between cognitive function and the course of depression.
METHOD: A sample of patients (n=73) in a depressive episode (major depression or bipolar disorder) was tested with a comprehensive battery of attention and executive tasks at both admission and discharge. In addition, response to pharmacological treatment and remission was assessed with standardized rating scales. Nineteen patients, recovered from depression, were re-investigated 6 months after discharge to determine whether specific cognitive parameters were related to subsequent relapse.
RESULTS: On admission, patients were impaired in almost all cognitive tasks. At discharge, we found a significant reduction in psychopathology, but only marginal cognitive improvements. Non-responders after 4 weeks of antidepressive medication and subjects who did not achieve remission prior to discharge were specifically impaired in divided attention on admission (p < 0.05). In addition, a trend was found for the association between impaired divided attention at discharge and an elevated risk to relapse (p < 0.10).
CONCLUSIONS: We observed generalized cognitive impairment in most cognitive domains in acute depression. Cognitive impairments were still within abnormal ranges at discharge but less distinct. Divided attention performance predicted response to treatment, remission of symptoms, and risk to relapse. Impaired divided attention capacity can be explained either by reduced attentional resources or impaired activation and/or top-down control of attentional resources by the central executive.

Entities:  

Mesh:

Year:  2004        PMID: 15724876     DOI: 10.1017/s0033291704002697

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  46 in total

1.  Internally vs. externally triggered movements in patients with major depression.

Authors:  Felix Hoffstaedter; Jan Sarlon; Christian Grefkes; Simon B Eickhoff
Journal:  Behav Brain Res       Date:  2011-11-28       Impact factor: 3.332

Review 2.  A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression.

Authors:  Monique A Pimontel; David Rindskopf; Bret R Rutherford; Patrick J Brown; Steven P Roose; Joel R Sneed
Journal:  Am J Geriatr Psychiatry       Date:  2015-05-21       Impact factor: 4.105

Review 3.  [Executive functions in patients with depression. The role of prefrontal activation].

Authors:  N Vasic; R C Wolf; H Walter
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

4.  Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.

Authors:  Paul G Unschuld; Suresh E Joel; James J Pekar; Sarah A Reading; Kenichi Oishi; Julie McEntee; Megan Shanahan; Arnold Bakker; Russell L Margolis; Susan S Bassett; Adam Rosenblatt; Susumu Mori; Peter C van Zijl; Christopher A Ross; Graham W Redgrave
Journal:  Psychiatry Res       Date:  2012-09-11       Impact factor: 3.222

5.  Improving outcome for mental disorders by enhancing memory for treatment.

Authors:  Allison G Harvey; Jason Lee; Rita L Smith; Nicole B Gumport; Steven D Hollon; Sophia Rabe-Hesketh; Kerrie Hein; Michael R Dolsen; Kirsten L Haman; Jennifer C Kanady; Monique A Thompson; Deidre Abrons
Journal:  Behav Res Ther       Date:  2016-04-02

6.  Is low cognitive functioning a predictor or consequence of major depressive disorder? A test in two longitudinal birth cohorts.

Authors:  Jonathan D Schaefer; Matthew A Scult; Avshalom Caspi; Louise Arseneault; Daniel W Belsky; Ahmad R Hariri; Honalee Harrington; Renate Houts; Sandhya Ramrakha; Richie Poulton; Terrie E Moffitt
Journal:  Dev Psychopathol       Date:  2017-11-16

Review 7.  Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.

Authors:  G Voegeli; M L Cléry-Melin; N Ramoz; P Gorwood
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

8.  Learning cognitive behavior therapy.

Authors:  Nicole B Gumport; Joseph J Williams; Allison G Harvey
Journal:  J Behav Ther Exp Psychiatry       Date:  2015-04-10

Review 9.  Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders.

Authors:  Thomas Prévot; Etienne Sibille
Journal:  Mol Psychiatry       Date:  2020-04-28       Impact factor: 15.992

10.  Cognitive functioning in major depression--a summary.

Authors:  Asa Hammar; Guro Ardal
Journal:  Front Hum Neurosci       Date:  2009-09-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.